WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Scientists glue two proteins together, driving cancer cells to self-destruct

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest
Oncology November 09,2024
Scientists glue two proteins together, driving cancer cells to self-destruct

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest
Oncology November 09,2024
New CAR-T cells offer on-demand control for cancer treatment

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c
Oncology November 09,2024
New CAR-T cells offer on-demand control for cancer treatment

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c
Oncology November 09,2024
Researchers unveil inhibition mechanism of receptors on natural killer cells

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh
Oncology November 09,2024
Researchers unveil inhibition mechanism of receptors on natural killer cells

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh
Oncology November 09,2024
Pembrolizumab aids survival with high-risk endometrial cancer

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl
Oncology November 09,2024
Pembrolizumab aids survival with high-risk endometrial cancer

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl
Oncology November 09,2024
Immune cell discovery offers new potential for cancer immunotherapy

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ
Oncology November 09,2024
Immune cell discovery offers new potential for cancer immunotherapy

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ
Oncology November 09,2024
Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit
Oncology November 09,2024
Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit
Oncology November 09,2024
Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines
Oncology November 09,2024
Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines
Oncology November 09,2024
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur
Oncology November 09,2024
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur
Oncology November 09,2024
Cancer detection recovered following pandemic disruptions

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in
Oncology November 09,2024
Cancer detection recovered following pandemic disruptions

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in
Oncology November 09,2024
Polyploidy study reveals why some cancers are resistant to therapeutic drugs

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea
Oncology November 09,2024
Polyploidy study reveals why some cancers are resistant to therapeutic drugs

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea
Oncology November 09,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com